seed
Stage
About
HEPHAISTOS-Pharma is a biopharmaceutical company developing third-generation innate immune boosters, specifically a TLR4 agonist drug candidate HEPHA440, aimed at converting myeloid-rich tumors into tumors responsive to immunotherapy for cancer treatment.
Explore HEPHAISTOS-Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.